Search

everythinglearnresearchcommunity

for

Search:↓

Some side effects of breast cancer chemotherapy, like neuropathy and nail loss, can last long after treatment.

Anxiety and depression were present but didn't affect overall quality of life in breast cancer patients on chemotherapy.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Ayurveda-based care may improve quality of life for breast cancer patients without serious side effects.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Patients should discuss complementary medicine use with doctors to improve health outcomes.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Scalp cooling helps prevent hair loss during chemotherapy for breast cancer.

Spiritual well-being improves quality of life for Palestinian women with breast cancer.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Spiritual well-being is crucial for improving quality of life in women with breast cancer.

Better awareness of chemotherapy's side effects improves self-care.

Oncologists should better understand the unique impact of hair loss on Black breast cancer patients to offer more compassionate care.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

Both scalp cooling and chemical cooling caps effectively prevent hair loss in breast cancer patients undergoing chemotherapy.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Personalized hair care strategies are needed for Black cancer patients to prevent hair loss during chemotherapy.

Xiaoaiping reduces chemotherapy side effects and improves quality of life for breast cancer patients.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.